DK0965040T3 - Fremgangsmåder og midler i relation til retrotransposon og retroviral integration - Google Patents
Fremgangsmåder og midler i relation til retrotransposon og retroviral integrationInfo
- Publication number
- DK0965040T3 DK0965040T3 DK98900593T DK98900593T DK0965040T3 DK 0965040 T3 DK0965040 T3 DK 0965040T3 DK 98900593 T DK98900593 T DK 98900593T DK 98900593 T DK98900593 T DK 98900593T DK 0965040 T3 DK0965040 T3 DK 0965040T3
- Authority
- DK
- Denmark
- Prior art keywords
- agents
- retrotransposon
- relation
- methods
- retroviral integration
- Prior art date
Links
- 230000010354 integration Effects 0.000 title abstract 2
- 230000001177 retroviral effect Effects 0.000 title abstract 2
- 230000037361 pathway Effects 0.000 abstract 3
- 230000033616 DNA repair Effects 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 102100036973 X-ray repair cross-complementing protein 5 Human genes 0.000 abstract 1
- 101710124921 X-ray repair cross-complementing protein 5 Proteins 0.000 abstract 1
- 102100036976 X-ray repair cross-complementing protein 6 Human genes 0.000 abstract 1
- 101710124907 X-ray repair cross-complementing protein 6 Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 230000001413 cellular effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000005764 inhibitory process Effects 0.000 abstract 1
- 210000004962 mammalian cell Anatomy 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 241001430294 unidentified retrovirus Species 0.000 abstract 1
- 210000005253 yeast cell Anatomy 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/9015—Ligases (6)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Gyroscopes (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Dental Preparations (AREA)
- Financial Or Insurance-Related Operations Such As Payment And Settlement (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9700574.8A GB9700574D0 (en) | 1997-01-13 | 1997-01-13 | Methods and means relating to retrotransposon and retroviral integration |
| PCT/GB1998/000099 WO1998030903A1 (en) | 1997-01-13 | 1998-01-13 | Methods and means relating to retrotransposon and retroviral integration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0965040T3 true DK0965040T3 (da) | 2003-07-21 |
Family
ID=10805892
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98900593T DK0965040T3 (da) | 1997-01-13 | 1998-01-13 | Fremgangsmåder og midler i relation til retrotransposon og retroviral integration |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6242175B1 (da) |
| EP (1) | EP0965040B1 (da) |
| JP (1) | JP2001508175A (da) |
| AT (1) | ATE237135T1 (da) |
| AU (1) | AU729066B2 (da) |
| CA (1) | CA2277483A1 (da) |
| DE (1) | DE69813193T2 (da) |
| DK (1) | DK0965040T3 (da) |
| ES (1) | ES2197454T3 (da) |
| GB (2) | GB9700574D0 (da) |
| PT (1) | PT965040E (da) |
| WO (1) | WO1998030903A1 (da) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9907687D0 (en) * | 1999-04-01 | 1999-05-26 | Kudos Pharm Ltd | Assays methods and means |
| US6569681B1 (en) * | 2000-03-14 | 2003-05-27 | Transkaryotic Therapies, Inc. | Methods of improving homologous recombination |
| CA2414017A1 (en) * | 2000-05-30 | 2001-12-06 | Kudos Pharmaceuticals Limited | Inhibiting retrotransposon and retroviral integration by targeting the atm pathway |
| US7358040B2 (en) * | 2001-08-01 | 2008-04-15 | Rigel Pharmaceuticals, Incorporated | MRE 11: modulation of cellular proliferation |
| US7106469B2 (en) * | 2001-08-08 | 2006-09-12 | Hewlett-Packard Development Company, L.P. | Variable data printing with web based imaging |
| WO2003027237A2 (en) * | 2001-09-24 | 2003-04-03 | Blood Center Research Foundation | Method of modulating or examining ku70 levels in cells |
| US20050158724A1 (en) * | 2002-04-05 | 2005-07-21 | Fishel Richard A. | Methods, of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof |
| WO2003094847A2 (en) * | 2002-05-07 | 2003-11-20 | Emory University | Compositions and methods for identifying antiviral agents |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07505057A (ja) * | 1993-01-21 | 1995-06-08 | ザ サルク インスティテュート フォー バイオロジカル スタディーズ | プロテインキナーゼ |
| AU7972594A (en) | 1993-10-12 | 1995-05-04 | Baylor College Of Medicine | Hepatitis b virus interacts with cellular dna repair processes |
-
1997
- 1997-01-13 GB GBGB9700574.8A patent/GB9700574D0/en active Pending
-
1998
- 1998-01-13 PT PT98900593T patent/PT965040E/pt unknown
- 1998-01-13 DK DK98900593T patent/DK0965040T3/da active
- 1998-01-13 CA CA002277483A patent/CA2277483A1/en not_active Abandoned
- 1998-01-13 JP JP53067198A patent/JP2001508175A/ja not_active Ceased
- 1998-01-13 ES ES98900593T patent/ES2197454T3/es not_active Expired - Lifetime
- 1998-01-13 US US09/341,515 patent/US6242175B1/en not_active Expired - Fee Related
- 1998-01-13 EP EP98900593A patent/EP0965040B1/en not_active Expired - Lifetime
- 1998-01-13 AT AT98900593T patent/ATE237135T1/de not_active IP Right Cessation
- 1998-01-13 GB GB9800660A patent/GB2321702B/en not_active Expired - Fee Related
- 1998-01-13 DE DE69813193T patent/DE69813193T2/de not_active Expired - Fee Related
- 1998-01-13 AU AU55684/98A patent/AU729066B2/en not_active Ceased
- 1998-01-13 WO PCT/GB1998/000099 patent/WO1998030903A1/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP0965040A1 (en) | 1999-12-22 |
| ATE237135T1 (de) | 2003-04-15 |
| GB2321702B (en) | 1998-12-23 |
| ES2197454T3 (es) | 2004-01-01 |
| PT965040E (pt) | 2003-08-29 |
| US6242175B1 (en) | 2001-06-05 |
| WO1998030903A1 (en) | 1998-07-16 |
| DE69813193D1 (de) | 2003-05-15 |
| CA2277483A1 (en) | 1998-07-16 |
| AU729066B2 (en) | 2001-01-25 |
| AU5568498A (en) | 1998-08-03 |
| JP2001508175A (ja) | 2001-06-19 |
| EP0965040B1 (en) | 2003-04-09 |
| GB2321702A (en) | 1998-08-05 |
| DE69813193T2 (de) | 2004-03-04 |
| GB9700574D0 (en) | 1997-03-05 |
| GB9800660D0 (en) | 1998-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Stewart et al. | Novel species of tRNA | |
| DE69802191D1 (de) | Festphase nukleinsäure-isolierung | |
| DE69628959D1 (de) | Stabilisierte Zusammensetzungen von Reverser Transkriptase und RNA Polymerase für Nukleinsäureamplifikation | |
| DE60144517D1 (de) | Rekombinante konstrukte und ihre verwendung bei der reduzierung der genexpression | |
| DE69940265D1 (de) | Alzheimersche krankheit sekretase | |
| DK1266018T3 (da) | Fremstilling af udskilte proteiner af rekombinante, eukaryotiske celler | |
| ATE404684T1 (de) | Methoden und zusammensetzungen zur transformation von zellen | |
| BR9507678A (pt) | Construção de dna vetor de expressão recombinante célula proceso para produzir uma enzima enzima preparação de enzima uso da enzima e cultura | |
| DE69830312D1 (de) | Methode zur spezifischen integration von genen in säugetierzellen durch homologe rekombination, und vektoren zu deren durchführung | |
| DE69030449D1 (de) | Verfahren und kit zur reinigung von nukleinsäure | |
| DK0965040T3 (da) | Fremgangsmåder og midler i relation til retrotransposon og retroviral integration | |
| ATE361668T1 (de) | Kombinierte tumor suppressor-gen-therapie und chemotherapie bei der neoplasmabehandlung | |
| ES2134924T3 (es) | Acidos sulfonilalcanoilamino-hidroxietilamino-sulfamicos utiles como inhibidores de proteasas retrovirales. | |
| CA2263713A1 (en) | Lyophilization of cultured human cells to preserve rna and dna | |
| PT942999E (pt) | Construcao armadilha de genes para a identificacao e isolamento de genes | |
| Ranu | Regulation of protein synthesis in rabbit reticulocyte lysates: The heme-regulated protein kinase (Hri) and double stranded rna induced protein kinase (Dri) phosphorylate the same Site (S) on initiation factor eif-2 | |
| NO20000576D0 (no) | Blanding og fremgangsmåte for regulering av celleproliferasjon og celledoed | |
| DK264890D0 (da) | Fremgangsmaade til biokemisk oxidation af steroider og genetisk konstruerede celler til denne anvendelse | |
| DE69836641D1 (de) | Gebrauch von beta-rekombinase in eukaryotischen zellen, speziell für transgene arbeiten | |
| DK0994955T3 (da) | Öget produktion af secernerede proteiner med rekombinante gærceller | |
| DK0973918T3 (da) | Gærceller, der omfatter mindst to kopier af et önsket gen integreret i det kromosomale genom ved mere end et ikke-ribosomalt RNA-kodende domæne, navnlig med Kluyveromyces | |
| AUPQ923400A0 (en) | Assays for alternative lengthening of telomeres | |
| DE69331708D1 (de) | Von enzymen katalysierte chemilumineszente detektion von proteinen und nukleinsäuren durch verwendung von hydroxyaryl-cyclischen diacylhydrazid-zusammensetzungen |